Scope
What is the incidence of lung cancer in the general population?
Definition
| Rate (age, sex ratio)
|
Context (population size studied, location, date data taken, end-point measured)
|
Definition of end-point
|
Reference
|
375,000 cases (estimate)
303,000 in men
72,000 in women
Estimated number of resulting deaths = 347,000 (280,000 in men and 67,000 in women).
| Estimates of lung-cancer incidence in Europe, 2000
|
|
|
Men
|
Women
|
| Country
|
Crude rate
|
ASR
|
Cumulative risk*
|
No of cases
|
Crude rate
|
ASR
|
Cumulative risk*
|
No of cases
|
| Eastern Europe
|
87.2
|
69•7
|
4•4
|
126 653
|
79•2
|
63•1
|
3•8
|
115 091
|
| Northern Europe
|
73.5
|
44•3
|
1•9
|
33 976
|
75•7
|
45•1
|
1•8
|
35 007
|
| Southern Europe
|
95.9
|
58•8
|
3•2
|
67 518
|
84•4
|
50•4
|
2•5
|
59 426
|
| Western Europe
|
83.9
|
53•2
|
2•9
|
75 350
|
79•1
|
48•9
|
2•3
|
71 024
|
| *Cumulative risks are for ages 0–64 years. ASR, age-standardised rate.
|
|
Europe, 2000
|
|
[1]
|
| Relative risk of lung cancer in European men and women
|
|
|
Men
|
Women
|
| Squamous-cell and small-cell carcinoma
|
Adenocarcinoma
|
Squamous-cell and small-cell carcinoma
|
Adenocarcinoma
|
| Non-smoker
|
1•0
|
1•0
|
1•0
|
1•0
|
| Ex-smoker
|
16•2*
|
3•5*
|
3•8*
|
1•1
|
| Current smoker
|
57•9*
|
8•0*
|
18•2*
|
4•1*
|
| * p<0•05
|
| Table 2. Effects of smoking cessation on lung-cancer risk
|
|
|
Relative risk
|
| Time since stopping
|
Men
|
Women
|
| Current smokers
|
1•00
|
1•00
|
| 2–9 years
|
0•66*
|
0•41*
|
| 10–19 years
|
0•27*
|
0•19*
|
| 20–29 years
|
0•17*
|
0•08*
|
| >30 years
|
0•08*
|
0•13*
|
| Non-smokers
|
0•04*
|
0•11*
|
| * p<0•05
|
|
n=7,609 with 10,431 controls, 10 case-control studies of lung cancer in 6 countries from 1988 to 1994: Sweden, Germany, United Kingdom, France, Spain, Italy. Lung cancer
|
|
[2]
|
| Number of new cases and rates of lung cancer, UK, 2006
|
|
|
England
|
Wales
|
Scotland
|
N.Ireland
|
UK
|
| Cases
|
| Males
|
18,026
|
1,299
|
2,509
|
547
|
22,381
|
| Females
|
13,141
|
984
|
2,177
|
344
|
16,646
|
| Persons
|
31,167
|
2,283
|
4,686
|
891
|
39,027
|
| Crude rate per 100,000 population
|
| Males
|
72.3
|
89.9
|
101.6
|
64.1
|
75.4
|
| Females
|
50.9
|
64.7
|
82.2
|
38.7
|
53.9
|
| Persons
|
61.4
|
77.0
|
91.6
|
51.2
|
64.4
|
| Age-standardised rate (European) per 100,000 population
|
| Males
|
58.3
|
65.8
|
81.7
|
60.8
|
60.8
|
| 95% CI
|
57.5
|
59.2
|
62.2
|
69.4
|
78.5
|
84.9
|
55.7
|
65.9
|
60.0
|
61.5
|
| Females
|
35.0
|
40.9
|
55.1
|
31.5
|
37.1
|
| 95% CI
|
34.4
|
35.6
|
38.3
|
43.4
|
52.8
|
57.4
|
28.2
|
34.9
|
36.5
|
37.6
|
| Persons
|
45.2
|
51.9
|
66.2
|
44.3
|
47.4
|
| 95% CI
|
44.7
|
45.7
|
49.8
|
54.0
|
64.3
|
68.1
|
41.4
|
47.2
|
46.9
|
47.9
|
|
UK, 2006, lunch cancer
|
Doctor diagnosed
|
[3]
|
|
|
INCIDENCE
|
MORTALITY
|
| MALE
|
FEMALE
|
MALE
|
FEMALE
|
| ASR
|
Cumulative risk
|
ASR
|
Cumulative risk
|
ASR
|
Cumulative risk
|
ASR
|
Cumulative risk
|
| (World)
|
(age 0–64)
|
(World)
|
(age 0-64)
|
(World)
|
(age 0–64)
|
(World)
|
(age 0-64)
|
| E. Europe
|
257.7
|
14.1
|
175.1
|
10.8
|
197.2
|
10.4
|
101.9
|
5.6
|
| N. Europe
|
283.1
|
11.7
|
252.3
|
14.0
|
161.0
|
5.8
|
118.1
|
5.2
|
| S. Europe
|
299.4
|
14.2
|
208.1
|
12.0
|
170.1
|
7.1
|
92.2
|
4.2
|
| W. Europe
|
326.4
|
15.5
|
244.6
|
14.1
|
173.9
|
7.0
|
106.1
|
4.6
|
| World
|
209.6
|
10.3
|
161.5
|
9.5
|
137.7
|
6.4
|
92.1
|
4.9
|
|
Worldwide, 1993-2001 with population estimates from 2002 to estimate 2002 cancer burden, from GLOBOCAN database, lung cancer
|
|
[4]
|
| Total prevalence by country and age class. Proportions per 100000 persons
|
|
|
Men
|
Women
|
| 0-44
|
45-64
|
65+
|
All ages
|
0-44
|
45-64
|
65+
|
All ages
|
| Netherlands
|
3.3
|
276.5
|
1468.0
|
197.4
|
3.1
|
79.3
|
101.1
|
33.1
|
| Germany
|
5.6
|
246.5
|
907.4
|
168.0
|
2.3
|
51.3
|
100.1
|
33.1
|
| Austria
|
5.7
|
201.5
|
610.0
|
103.1
|
3.9
|
68.9
|
111.1
|
33.9
|
| Switzerland
|
6.4
|
215.0
|
721.6
|
145.8
|
3.4
|
71.6
|
144.0
|
45.9
|
| Slovenia
|
7.5
|
262.1
|
672.0
|
118.9
|
1.5
|
36.1
|
60.5
|
17.8
|
| Slovakia
|
6.3
|
398.6
|
1390.4
|
206.5
|
2.0
|
40.3
|
141.5
|
28.1
|
| Poland
|
5.5
|
216.2
|
424.5
|
100.0
|
2.9
|
57.3
|
103.9
|
32.6
|
| All Euro countries (n=17)
|
3.8
|
201.5
|
791.5
|
144.1
|
2.2
|
59.7
|
166.1
|
44.2
|
|
Austria, Germany, The Netherlands, Poland, Slovakia, Slovenia and Switzerland, 1970-1992, lung cancer
|
|
[5]
|
Result
{{#opasnet_base_link:Op_en4536}}
See also
Related files
<mfanonymousfilelist></mfanonymousfilelist>
References
- ↑ J.Tyczynski, F.Bray, D.Maxwell Parkin. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. The Lancet Oncology, Volume 4, Issue 1, Pages 45-55.
- ↑ Simonato L, Agudo A, Ahrens W, et al. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer 2001; 91: 876–87.
- ↑ http://info.cancerresearchuk.org/cancerstats/types/lung/incidence/index.htm
- ↑ D. Max Parkin, Freddie Bray, J. Ferlay and Paola Pisani. Global Cancer Statistics, 2002. CA Cancer J Clin. 2005;55;74-108
- ↑ J. M. Lutz, S. Francisci, E. Mugno, M. Usel, V. Pompe-Kirn, J.-W. Coebergh & M. Bieslka-Lasota. Cancer prevalence in Central Europe: the EUROPREVAL Study. Annals of Oncology, 2003, 14: 313–322.
